Category
Biologics & Advanced Therapies
Modern targeted treatments for moderate-severe IBD
Tremfya vs Omvoh for Ulcerative Colitis: Which to Choose?
Tremfya vs Omvoh for ulcerative colitis: compare remission data, bowel urgency outcomes, induction routes and dosing to choose with your GI.
Tremfya vs Omvoh for Crohn's Disease: Key Differences
Tremfya vs Omvoh for Crohn's disease: compare trial evidence, induction routes, dosing, injections and safety, then prepare to talk with your GI.
Tremfya vs Humira for Ulcerative Colitis: Which Is Right?
Tremfya vs Humira for ulcerative colitis: compare trial evidence, onset, safety, dosing and cost, then prepare key questions for your GI.
Tremfya vs Humira for Crohn's Disease: Key Differences
Tremfya vs Humira for Crohn's: compare efficacy, onset, infection risks, dosing, and cost, including SC or IV induction and biosimilar access.
Tremfya vs Entyvio for Ulcerative Colitis: A Comparison
Compare Tremfya and Entyvio for ulcerative colitis by remission data, onset, infection risk, and IV or SC dosing, then prepare questions for your GI.
Tremfya vs Entyvio for Crohn's Disease: How They Compare
Tremfya vs Entyvio for Crohn's: compare efficacy, safety, onset timelines at weeks 12 and 14, plus IV and SC dosing, to prepare for your GI visit.
Stelara vs Remicade for Ulcerative Colitis: A Comparison
Comparing Stelara and Remicade for UC? Review remission evidence, 4% vs 7% serious infection hospitalizations, dosing and switching guidance.
Stelara vs Humira for Ulcerative Colitis: Key Differences
Compare Stelara and Humira for ulcerative colitis on efficacy, safety, response time and maintenance dosing every 2 vs 8 weeks. Prepare for your GI visit.
Skyrizi vs Tremfya for Ulcerative Colitis: Comparing IL-23s
Skyrizi vs Tremfya for ulcerative colitis: compare week 12 remission data, IV vs SC induction, maintenance dosing, safety, and injection devices.
Skyrizi vs Tremfya for Crohn's Disease: Which Is Right?
Compare Skyrizi vs Tremfya for Crohn's disease by trial evidence, dosing, injection devices, safety and access, including Tremfya's SC induction.
Skyrizi vs Stelara for Ulcerative Colitis: A Comparison
Skyrizi vs Stelara for ulcerative colitis: compare trial evidence, safety, onset and every-8-week dosing, then prepare questions for your GI.
Skyrizi vs Stelara for Crohn's Disease: SEQUENCE Trial Results
Skyrizi vs Stelara for Crohn's: compare SEQUENCE's 59% vs 40% clinical remission results, plus endoscopic outcomes, safety and dosing.